OS7.4 Calculating the net clinical benefit in brain tumor clinical trials by combining survival and health-related quality of life data using two methods: quality adjusted survival effect sizes (QASES) and joint modelling (JM)

BACKGROUND: The impact of treatment on both the quality and the quantity of life, i.e. the ‘net clinical benefit’, should be considered to inform glioma patients and facilitate shared decision making. We applied two methods (i.e. Quality Adjusted Effect Sizes (QASES) and Joint Modelling (JM)) that c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Coomans, M, Dirven, L, Bottomley, A, van den Bent, M, Sloan, J, Stupp, R, Weller, M, Reijneveld, J C, Taphoorn, M, Aaronson, N, Baumert, B G, Brandes, A A, Chinot, O, Coens, C, Gorlia, T, Herrlinger, U, Keime-Guibert, F, Malmström, A, Martinelli, F, Talacchi, A, Wick, W
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Oral Presentations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795111/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.047
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller